A 2012 Evidence-Based Algorithm for the Pharmacotherapy for Obsessive-Compulsive Disorder-Reference-Cited by-同舟云学术

A 2012 Evidence-Based Algorithm for the Pharmacotherapy for Obsessive-Compulsive Disorder

Published:2012-04-13 Issue:3 Volume:14 Page:211-219
ISSN:1523-3812
Container-title:Current Psychiatry Reports
language:en
Short-container-title:Curr Psychiatry Rep

Author:

Stein Dan J.,Koen Nastassja,Fineberg Naomi,Fontenelle Leonardo F.,Matsunaga Hisato,Osser David,Simpson H. Blair

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11920-012-0268-9.pdf

Reference101 articles.

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.

2. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive compulsive disorder. Psychiatr Clin North Am. 2000;23(3):563–86.

3. Pauls DL. The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome. Psychiatr Clin North Am. 1992;15(4):759–66.

4. Pauls DL. The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med C Semin Med Genet. 2008;148C(2):133–9.

5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psilocybin in pharmacotherapy of obsessive-compulsive disorder;Pharmacological Reports;2024-08-01

2. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review;eClinicalMedicine;2024-04

3. Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings;Frontiers in Psychiatry;2024-01-09

4. Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder;Clinical Psychopharmacology and Neuroscience;2023-08-31

5. Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial;Frontiers in Psychiatry;2023-04-25